
From Option to Obligation: The Legal Imperative for NAMs
By Jo Anderson | August 7th, 2025
“Regulatory agencies must move from encouraging NAMs to requiring them where scientifically justified. Once merely regarded as alternatives to animal testing, NAMs have now emerged as a driving force in regulatory science.”
Image by NIH

NAMs and the Funding Frontier: How Modern Toxicology Maximizes Scientific Return on Investment
By Zachary Liebowitz | May 29th, 2025
“Funders are not only looking for scientific merit—they are also scrutinizing value and feasibility. NAMs answer all three.”
Image by ChatGPT